Trial Profile
Effect of Obeticholic Acid (INT-747, Intercept) on the Hepatobiliary Transport of Bile Acids in Patients With PBC Examined by 11C-cholyl-sarcosine PET/CT
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Primary biliary cirrhosis
- Focus First in man; Therapeutic Use
- 24 Jul 2020 Results assessing whether OCA treatment would influence hepatic transport of conjugated bile acids in patients with primary biliary cholangitis, published in the Journal of Hepatology
- 31 Oct 2019 Status changed from recruiting to completed.
- 23 Aug 2017 New trial record